AI reads your Heart's future: new software predicts 1-Year mortality risk from a simple ECG
NCT ID NCT07659262
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an artificial intelligence software that analyzes a standard 10-second ECG to predict the risk of dying from heart disease within one year. Researchers reviewed ECG data from over 460,000 patients across three hospitals in Taiwan. The goal was to see if the AI could accurately identify high-risk patients, potentially helping doctors make better decisions about long-term care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Chang Gung ECG Mortality Risk Prediction Software (AI software analyzing ECG signals)
What this could lead to
If successful, this AI tool could help doctors quickly identify patients at high risk of dying from heart disease within a year, enabling earlier intervention.
What could go wrong
This is a retrospective study, not a prospective trial, so real-world performance may differ. The AI was tested only in Taiwan, so results may not apply to other populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELECTROCARDIOGRAM are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaohsiung Armed Forces General Hospital
Kaohsiung City, 807, Taiwan
-
Taipei Municipal Wanfang Hospital
Taipei, 114, Taiwan
-
Tri-Service General Hospital
Taipei, 114, Taiwan